Farallon Capital Management LLC Chemo Centryx, Inc. Transaction History

Farallon Capital Management LLC

$19.9 Billion
Q3 2024

Shares

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2022 Nov 14, 2022	BUY	$22.17 - $51.8 $17.7 Million - $41.4 Million	800,000 New	800,000 $41.3 Million
Q4 2021 Feb 14, 2022	BUY	$18.38 - $40.5 $10.1 Million - $22.3 Million	549,463 Added 142.35%	935,463 $34.1 Million
Q3 2021 Nov 15, 2021	SELL	$13.18 - $19.83 $14.7 Million - $22.1 Million	-1,114,000 Reduced 74.27%	386,000 $6.6 Million
Q4 2019 Feb 13, 2020	SELL	$6.81 - $39.55 $3.5 Million - $20.3 Million	-513,396 Reduced 25.5%	1,500,000 $59.3 Million
Q3 2019 Nov 14, 2019	BUY	$6.47 - $8.96 $86,672 - $120,028	13,396 Added 0.67%	2,013,396 $13.7 Million
Q2 2019 Aug 14, 2019	BUY	$8.31 - $14.85 $4.16 Million - $7.43 Million	500,000 Added 33.33%	2,000,000 $18.6 Million
Q1 2019 May 15, 2019	BUY	$10.01 - $13.89 $500,500 - $694,500	50,000 Added 3.45%	1,500,000 $20.8 Million
Q4 2018 Feb 14, 2019	BUY	$9.15 - $12.26 $2.75 Million - $3.68 Million	300,000 Added 26.09%	1,450,000 $15.8 Million
Q2 2018 Aug 14, 2018	BUY	$10.62 - $13.98 $2.12 Million - $2.8 Million	200,000 Added 21.05%	1,150,000 $15.1 Million
Q1 2018 May 15, 2018	BUY	$5.9 - $14.99 $5.61 Million - $14.2 Million	950,000 New	950,000 $12.9 Million

Others Institutions Holding CCXI

# of Institutions

6

Shares Held

66.3K

Call Options Held

0

Put Options Held

0

About ChemoCentryx, Inc.

Ticker CCXI
Exchange NASDAQ
Shares Outstandng 71,919,696
Market Cap $3.68M
Description
ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...

More about CCXI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Farallon Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Farallon Capital Management LLC with notifications on news.